|
|||||
|
|
Resolving Resistance to Osimertinib Therapy With Afatinib in an NSCLC Patient With EGFR L718Q Mutation |
|
| Affiliation: | 1. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Medical Oncology, Peking University Cancer Hospital and Institute, Beijing, China;2. Thoracic Surgery Ward (C05), Beijing Hospital, National Center of Gerontology, Beijing, China;3. Geneplus-Beijing Institute, Beijing, China |
| Abstract: | |
| Keywords: | Concomitant mutation Loss of T790M |
| 本文献已被 ScienceDirect 等数据库收录！ | |